Search results for “Liver carcinoma” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 25 patents, we discovered top 17 key players by total patent application. Hiyoshi Corp., Fresenius Kabi Austria GmbH, Novartis AG are dominant in this area. They take 20.00% of the total patent filing.
Hiyoshi Corp.
Shiga-ken, Japan
Patent: 2
Fresenius Kabi Austria GmbH
Steiermark, Austria
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Warner-Lambert Co.
New Jersey, United States
Patent: 1
T&R Biofab Co., Ltd
South Korea
Patent: 1
GP Pharm SA
Spain
Patent: 1
NovaMedica LLC
undefined undefined
Patent: 1
Albireo AB
Sweden
Patent: 1
Raptor Pharmaceuticals Corp.
California, United States
Patent: 1
Proyecto de Biomedicina CIMA SL
NAVARRE, Spain
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Saint Leo University, Inc., Rhizen Pharmaceuticals AG, T&R Biofab Co., Ltd take 17.39% of patent filing during this period.
Saint Leo University, Inc.
United States
Patent: 2
Rhizen Pharmaceuticals AG
Neuchâtel, Switzerland
Patent: 1
T&R Biofab Co., Ltd
South Korea
Patent: 1
Shenzhen Innosai Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
NEXEL Co., Ltd.
South Korea
Patent: 1
Hefei University
Anhui Sheng, China
Patent: 1
Albireo AB
Sweden
Patent: 1
STARTUP
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Ping An Technology (Shenzhen) Co., Ltd.
Guangdong Sheng, China
Patent: 1
Korea Research Institute of Chemical Technology
South Korea
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 23 patents in last 5 years, we discover 11 new entrants. Saint Leo University, Inc., Rhizen Pharmaceuticals AG, T&R Biofab Co., Ltd are the most active new entrants in this area.
Saint Leo University, Inc.
United States
Patent: 2
Rhizen Pharmaceuticals AG
Neuchâtel, Switzerland
Patent: 1
T&R Biofab Co., Ltd
South Korea
Patent: 1
Shenzhen Innosai Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
NEXEL Co., Ltd.
South Korea
Patent: 1
Hefei University
Anhui Sheng, China
Patent: 1
Albireo AB
Sweden
Patent: 1
STARTUP
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Ping An Technology (Shenzhen) Co., Ltd.
Guangdong Sheng, China
Patent: 1
Korea Research Institute of Chemical Technology
South Korea
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 18 patents, we discovered top 8 universities and scientific research institutions by total patent application. Universidad Autónoma de Nuevo León, Saint Leo University, Inc., Um Al Qura University Of are dominant in this area. They take 33.33% of the total patent filing.
Universidad Autónoma de Nuevo León
Nuevo León, Mexico
Patent: 2
Saint Leo University, Inc.
United States
Patent: 2
Um Al Qura University Of
Saudi Arabia
Patent: 1
Ruhr-Universität Bochum
Nordrhein-Westfalen, Germany
Patent: 1
Hainan University
Hainan Sheng, China
Patent: 1
Hefei University
Anhui Sheng, China
Patent: 1
The Second Military Medical University
Shanghai Shi, China
Patent: 1
Jinling Institute of Technology
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: